Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elena Karabina"'
Autor:
Ilya Tsimafeyeu, Fedor Moiseenko, Sergei Orlov, Elena Filippova, Alexander Belonogov, Aleksey Nebesnykh, Amir Khalimov, Elena Karabina, Valentina Shikina, Ahmed Abdelgafur, Galina Statsenko, Irina Titova, Dmitry Isaichikov, Galina Makarnyaeva, Aleksey Mordovskiy, Oksana Barkovskaya, Aleksey Smirnov, Marina Gikalo, Nikita Savelov, Dmitry Kosov, Evgeny Imyanitov, Irina Demidova, Sergei Tjulandin
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-7 (2019)
PURPOSE: The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of cri
Externí odkaz:
https://doaj.org/article/2ab879efa3684da48f55386215f32008
Autor:
Inna P. Ganshina, Elena G. Ovchinnikova, Oksana M. Shalaeva, Svetlana V. Kuzmicheva, Alina N. Fedorova, Asiat I. Tekeeva, Alexander V. Sultanbaev, Elena V. Markizova, L G Zhukova, Ksenia S. Maistrenko, Svetlana A. Orlova, Irina V. Evstigneeva, Daniil L'vovich Stroyakovskiy, James J. Kolokolov, Olesya A. Kuchevskaya, Oksana N. Shirokova, Oksana I. Arapova, Elena V. Zueva, Anna V. Vasilevskaya, Tatyana A. Nersesova, Arshak A. Akopyan, Irina V. Kolyadina, Larisa Bolotina, Mariam Z. Yakubova, Sergey P. Medvedev, Alexandr S. Dergunov, Irina A. Shangina, Elvira A. Bobrova, Chulpan K. Valiakhmetova, Anna E. Storozhakova, Aleksei V. Emshanov, Natalia V. Fadeeva, Mikhail V. Volkonskiy, Yulia I. Merzlikina, Galina V. Antonova, Ivan A. Luev, Alisa R. Shumskikh, Natalia Yu. Samaneva, Elena Karabina, Natalia R. Abidova, Viktoria S. Egurenkova, Vasily V. Marfutov, Irina E. Gudkova, Lyubov Vladimirova, Olesya A. Stativko
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 68-76 (2021)
Relevance. Data on the efficacy of endocrine and chemotherapy regimens in patients with hormone-resistant metastatic breast cancer (mBC) after progression with CDK4/6 inhibitors are limited; the search for an effective therapy regimen in this clinica
Autor:
Mikhail V Shaidorov, Elena I. Simolina, Elena V. Artamonova, Denis A. Oskirko, Irina R. Suslova, Ekaterina A. Prokof’eva, Liudmila V. Kramskaia, Dmitrii V. Kozlov, Anton Iu Povyshev, Elena A. Gaisina, Irina I. Andreiashkina, Olga S. Frolova, Elena I. Kovalenko, Liudmila V. Vorotilina, Elena Karabina, Larisa A. Zhiliaeva, Tat'iana V Karandeeva, Guzel' Z Mukhametshina, Dmitrii M Ponomarenko, Artem O. Shepel, Al'fiia I Khasanova, Vasilii V. Marfutov, Valentina E Shikina, Irina V. Evstigneeva, Nataliia O. Popova, Anton E. Koziakov
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 53-59 (2020)
The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of metastatic HER2+ breast cancer in routine clinical practice. Aim. The main objective of this r
Autor:
Dmitry Kosov, Marina Gikalo, Sergei Tjulandin, Sergei V. Orlov, Fedor Moiseenko, Valentina Shikina, Irina Titova, Nikita Savelov, Ilya Tsimafeyeu, Alexander Belonogov, Ahmed Abdelgafur, I. A. Demidova, Galina Statsenko, Evgeny N. Imyanitov, Elena Karabina, Oksana Barkovskaya, Aleksey Smirnov, Galina Makarnyaeva, Amir Khalimov, Aleksey Nebesnykh, Aleksey Mordovskiy, E. Filippova, Dmitry Isaichikov
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-7 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of criz
Autor:
Natalia V. Zhukova, Svetlana Protsenko, Rashida Orlova, Evgeniy V Ledin, David R Naskhletashvili, Alexey Viktorovich Novik, Svetlana A Tkachenko, Fedor Moiseenko, Kristina V. Orlova, Sergey V Gamaunov, Aleksandr I Kazmin, Igor Samoylenko, Victor L Chang, Natalia N. Petenko, Elena Karabina, Irina Zh. Shubina, Lev V. Demidov, Daniil Stroyakovskiy, Galina Kharkevich, Aleksandr N Yurchenkov, Ludmila V Vorotilina, Igor A Utyashev, Mikhail V. Volkonskiy, Anastasia S Vikhrova
Publikováno v:
Cancers, Vol 13, Iss 2529, p 2529 (2021)
Cancers
Volume 13
Issue 11
Cancers
Volume 13
Issue 11
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked improvements in response and survival rates. However, real-world data on treatment patterns and clinical outcomes for patients w
Autor:
Mikhail A Osipov, Iuliia V Kostalanova, Elena Karabina, Vera A Gorbunova, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Elena M Cherniakova, Natalia V Strakhova, Tat'iana V Karandeeva, Natal'ia V Levchenko, Inna P. Ganshina, Guzel' Z Mukhametshina, S V Khokhlova, Mikhail V Shaidorov, Tat'iana Iu Semiglazova, Irina S Bulavina, Liubov' I Vladimirova, Elena V. Artamonova, Dzheims Dzh Kolokolov, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Larisa Bolotina, Natal'ia A Raevskaia, Igor' S Chernov, Oksana N Shkodenko, Dmitrii V Filonenko, N. O. Popova, V E Goldberg, Natal'ia M Tikhanovskaia, Irina V. Kolyadina, Sufiia Z Safina, Andrei E Orlov, Liudmila V Manziuk, Valentina E Shikina, Liudmila G. Zhukova, Irina V. Evstigneeva, Anton Iu Povyshev, Elena I. Kovalenko, Vladislav V Petkau
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials
Autor:
Natal'ia M Tikhanovskaia, Elena Karabina, Igor' S Chernov, Tat'iana V Karandeeva, Mikhail A Osipov, Irina V. Kolyadina, Ali-Dzarakhmat S Rzaev, Dmitrii V. Kozlov, Sufiia Z Safina, Vasilii V. Marfutov, Elena P Prokof'eva, Oksana N Shkodenko, Alena A Vazhenina, Tat'iana V Andreeva, Elena G. Ovchinnikova, Irina R. Suslova, Elena I. Kovalenko, Olga V Khrupalo, Tat'iana Iu Semiglazova, Liudmila V. Vorotilina, Irina I. Andreiashkina, Elena V. Artamonova, Anton Iu Povyshev, Angelina S Chichkanova, Olga V Romanchuk, Vera A Gorbunova, Liubov' I Vladimirova, Elena A. Gaisina, Garnik S Tumanian, Iuliia V Kostalanova, Liudmila A Gil'mutdinova, Irina S Mitashok, Liudmila V Manziuk, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Guzel' Z Mukhametshina, Vladimir I. Vladimirov, Dmitrii A Morozov, Liudmila V. Kramskaia, Mikhail V Shaidorov, V E Goldberg, Inna V Iudina, Valentina E Shikina, Liudmila G. Zhukova, N. O. Popova, Irina V. Evstigneeva, Anton E. Koziakov, Elena A Tul'china, Elena V Tiuvinova, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Dzheims Dzh Kolokolov, Anna S Belokhvostova, Natal'ia V Levchenko, Svetlana A Maklashova, Aleksandr N Ivanov, Larisa Bolotina, Anna V Tarasova, Dmitrii V Filonenko, Viacheslav A. Chubenko, Natal'ia A Raevskaia, Viktor M Sherstnev, Elena M Cherniakova, Tat'iana P Klement'eva, Larisa A Zhilyaeva
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Autor:
S. A. Varlamov, V.A. Chernyaev, S. Ch. Maykoparova, Larisa Bolotina, S. S. Kolesnikov, A. V. Shcherbinin, Maria Volkova, Ludmila A. Ryadinskaya, Kirill M. Nyushko, A. A. Lebedinets, A. L. Kornietskaya, A. E. Storozhakova, Elena Karabina, I. S. Varlamov, B. Ya. Alekseev, A. A. Paichadze, Vsevolod Matveev, M. V. Odintsova, Evgeny Kopyltsov, N Yu Samaneva, Sergey N. Kabanov
Publikováno v:
Onkourologiâ, Vol 13, Iss 3, Pp 110-118 (2017)
Objective: to assess safety, responses rate and duration, progression-free and overall survival in patients with advanced urothelial carcinoma receiving vinflunine as second-line therapy in routine clinical practice, after additional patient recruitm
Autor:
Irina Vladimirovna Kolyadina, Larisa Bolotina, Lyudmila Zhukova, Liubov Yu Vladimirova, Alexander Sultanbaev, Elena Karabina, Inna Ganshina, Elena Ovchinnikova, Galina Antonova, Mikhail Volkonsky, James Kolokolov, Elena Zueva, I Akopyan, Natalia Fadeeva, Irina Evstigneeva, Svetlana Orlova, Anna Vasilevskaya, Oxana Shalaeva, Oxana Shirokova
Publikováno v:
Journal of Clinical Oncology. 39:e13035-e13035
e13035 Background: EMPOWER trial demonstrated the benefit of eribulin administrated post CD4/6i in patients (pts) with HR+ HER2-negative (HR+HER2-) metastatic breast cancer (MBC). There are several important limitations to this trial: > 60% of pts we
Autor:
S V Limareva, Irina V. Evstigneeva, A. E. Storozhakova, E P Prokofyeva, Elena Karabina, L V Manziuk, Irina L. Popova, N Yu Samaneva, Natalya A Abramova, Elena A. Kalabanova, Natalya Mikhailovna Tikhanovskaya, Viacheslav Chubenko, Larisa Bolotina, I. S. Mitashok, L Yu Vladimirova, I I Andreyashkina, Elena Kovalenko, Vera Gorbunova, Guzel Mukhametshina, Alfia Khasanova, Ya. V. Svetitskaya, A A Teterich, E A Gaysina, T A Snezhko
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 27-32 (2016)
The article shows the experience of eribulin application in actual clinical practice in Oncology institutions of the Russian Federation concerning metastatic breast cancer. We have analyzed the efficacy of the drug in case of different subtypes of th